An intranasal anti-viral medication for COVID-19 has been created that reduces the amount of SARS-CoV-2 shed by sick animals and prevents further transmission of the virus.
The COVID-19 medications now on the market treat the virus's symptoms but do little to stop it from spreading.
An innovative strategy for treating infectious diseases was earlier created by Gladstone Institutes researchers in the US.
They demonstrate how this therapy, known as a therapeutic interfering particle (TIP), also reduces restricts viral transmission in a recent study that was published by National Academy of Sciences.
The researchers stated that it is the only single-dose antiviral that decreases COVID-19 virus shedding in addition to symptoms and severity.
Leor Weinberger and Sonali Chaturvedi, a Gladstone research scientist and the study's first author.